medtigo Journal of Medicine

|Literature Review

| Volume 2, Issue 4

Recent Advances in Pain Management

  • 1

Author Affiliations

medtigo J Med. |
Date - Received: Oct 01, 2024,
Accepted: Oct 03, 2024,
Published: Oct 21, 2024.

https://doi.org/10.63096/medtigo30622432

Abstract

Pain is a complex, multidimensional experience, with chronic pain affecting over 20% of adults globally. This review discusses the evolution of pain management from historical opioid use to modern advancements in pharmacological and non-pharmacological strategies. Recent innovations include opioid alternatives like tramadol and buprenorphine, novel drug delivery systems such as transdermal patches, and adjuvant medications for neuropathic pain. Non-pharmacological approaches like physical therapy, cognitive-behavioral therapy, and integrative medicine are also explored. Interventional techniques, such as nerve blocks and spinal cord stimulation, represent promising alternatives. The article emphasizes the importance of multidisciplinary care models that integrate personalized treatment plans and patient-centered decision-making. Continuous research and innovation are vital to improving outcomes in pain management.

Keywords

Pain management, Pharmacological advances, Non-pharmacological advances, Opioid.

Introduction

The International association for the study of pain (IASP) defines pain as ‘An unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage.’ Pain is a complex and multifaceted phenomenon that poses significant challenges for patients and healthcare providers alike.[1]

Pain is always a personal experience that is influenced to varying degrees by biological, psychological, and social factors. With chronic pain affecting over 20% of adults worldwide, the search for effective pain management strategies has never been more urgent. Our review synthesizes the latest research findings and clinical developments in pain management, offering insights into the current state of the field and future directions for research and practice.

Background
Back in the 17th century, opium was frequently used by European doctors as an effective pain relief. Passing on to the 19th century, chloroform and ether were used to anaesthetize patients who underwent surgery. Then, starting from the 1900s, heroine and morphine were employed as pain medications. In that era, the subject of chronic pain without any obvious pathology also captured great interest. Before that, pain was usually regarded as an acute problem related to surgery, injury, or painful death due to cancer.

Pain medicine was then established as a field of its own in the 1960s with its dedicated association and research journal. The concept of an interdisciplinary approach for pain control was also introduced, and doctors working in pain teams started to collaborate with doctors in other fields of medicine to devise a comprehensive pain management plan.

Pain Management

Pharmacological Advances
Pharmacological interventions play a crucial role in pain management, offering clinicians a diverse range of options to effectively alleviate pain and improve patient outcomes.[2] Recent advancements in pharmacotherapy have focused on enhancing the efficacy, safety, and tolerability of analgesic medications, as well as exploring novel drug targets and delivery systems. This section will explore some of the significant pharmacological advances in pain management and their implications for clinical practice.

Opioid Alternatives: In response to the opioid epidemic and concerns about opioid-related adverse effects, there has been growing interest in identifying alternative analgesic agents with fewer side effects and lower abuse potential.[3] Several classes of drugs have emerged as promising opioid alternatives:

  • Tramadol: Tramadol is a centrally acting analgesic that exerts its effects through two mechanisms: weak mu-opioid receptor agonism and inhibition of serotonin and norepinephrine reuptake. This unique mechanism of action provides effective pain relief with a lower risk of respiratory depression and addiction compared to traditional opioids.[4]
  • Tapentadol: Tapentadol is a centrally acting analgesic that combines mu-opioid receptor agonism with norepinephrine reuptake inhibition. This dual mechanism of action provides potent analgesia with fewer opioid-related adverse effects, such as constipation and respiratory depression.[5]
  • Buprenorphine: Buprenorphine is a partial mu-opioid receptor agonist and kappa-opioid receptor antagonist. It has high affinity and slow dissociation from the mu-opioid receptor, leading to a ceiling effect for respiratory depression and a lower risk of abuse and dependence.[6]

Adjuvant Medications: Adjuvant medications are drugs that are not primarily used for pain relief but can enhance the analgesic effects of traditional analgesics or target specific pain mechanisms.[7] They are commonly used in combination with opioids or non-opioid analgesics to manage neuropathic pain and other chronic pain conditions. Some notable adjuvant medications include:

  • Antidepressants: Tricyclic antidepressants (TCAs) such as amitriptyline and nortriptyline are commonly used for neuropathic pain due to their effects on inhibiting the reuptake of serotonin and norepinephrine.[8]
  • Anticonvulsants: Anticonvulsant medications such as gabapentin and pregabalin are widely used for neuropathic pain and fibromyalgia. They exert their effects by modulating calcium channels and reducing excitatory neurotransmitter release in the central nervous system.[9]
  • N-methyl-D-aspartate (NMDA) Receptor Antagonists: NMDA receptor antagonists such as ketamine and memantine have been investigated for their potential role in treating neuropathic pain. These drugs block the NMDA receptor, which plays a key role in central sensitization and pain amplification.[10]

Novel drug delivery systems (NDDS): Advancements in drug delivery technology have revolutionized the way analgesic medications are administered, allowing for more targeted and controlled delivery of drugs to specific sites of action.[11] Some innovative drug delivery systems include:

  • Transdermal Patches: Transdermal patches deliver medications through the skin, allowing for continuous and controlled drug release over an extended period. Drugs such as buprenorphine and lidocaine are available in patch formulations for the management of chronic pain conditions.[12]
  • Intrathecal drug delivery systems: Intrathecal drug delivery systems deliver medications directly into the intrathecal space of the spinal cord via implanted pumps and catheters. This route of administration bypasses the blood-brain barrier and systemic circulation, allowing for lower drug doses and reduced systemic side effects.[13]
  • Liposomal formulations: Liposomal formulations encapsulate drugs within lipid vesicles, allowing for controlled release and targeted delivery to specific tissues or cells. Liposomal formulations improve drug solubility, stability, and bioavailability while reducing systemic toxicity.[14]

These recent pharmacological advances offer clinicians a diverse array of options to effectively manage pain while minimizing adverse effects and optimizing patient outcomes. By leveraging these advancements, healthcare providers can tailor treatment approaches to individual patient needs and improve overall quality of care.

Non-Pharmacological Advances
Non-pharmacological approaches to pain management encompass a wide range of modalities aimed at addressing the multidimensional nature of pain and promoting overall well-being.[15] These approaches include physical therapy, mind-body interventions, integrative medicine, and complementary therapies. This section will explore recent advances in non-pharmacological pain management and their applications in clinical practice.

Physical therapy and exercise: Physical therapy and exercise are integral components of pain management, offering targeted rehabilitation and pain relief for patients with acute and chronic pain conditions.[16] Recent advancements in physical therapy techniques, such as manual therapy and exercise prescription, have focused on improving functional outcomes and reducing disability in patients with musculoskeletal pain.

  1. Manual therapy: Manual therapy techniques such as manipulation, mobilization, and soft tissue massage are commonly used to reduce pain and improve mobility in patients with musculoskeletal pain conditions. Recent research has emphasized the importance of individualized treatment approaches and multimodal interventions in manual therapy practice.[17]
  2. Exercise Prescription: Exercise is a key component of pain management, promoting strength, flexibility, and cardiovascular health while reducing pain and disability. Recent advancements in exercise prescription have focused on tailoring interventions to individual patient needs and preferences, as well as integrating technology-based approaches such as tele-rehabilitation and wearable activity monitors.[18]
  3. Mind-body interventions: Mind-body interventions, such as mindfulness-based stress reduction (MBSR) and cognitive-behavioral therapy (CBT), have gained recognition for their effectiveness in managing chronic pain and improving psychological well-being.[19] Recent research has explored the neurobiological mechanisms underlying these interventions and their potential role in modulating pain perception and emotional processing.
  4. MBSR: MBSR is a structured program that combines mindfulness meditation, body awareness, and yoga to help individuals develop greater awareness and acceptance of their thoughts, emotions, and bodily sensations. Recent studies have shown that MBSR can reduce pain severity, improve pain-related disability, and enhance quality of life in patients with chronic pain conditions.[20]
  5. CBT: CBT is a psychotherapeutic approach that focuses on identifying and challenging maladaptive thoughts and behaviors associated with pain. Recent advancements in CBT have included the development of internet-based and smartphone-based interventions, as well as the integration of mindfulness-based techniques to enhance treatment efficacy and accessibility.[21]

Integrative medicine and complementary therapies: Integrative medicine combines conventional medical treatments with evidence-based complementary therapies to address the physical, emotional, and spiritual aspects of health and healing.[22] Recent advancements in integrative medicine have focused on expanding the evidence base for complementary therapies and promoting interdisciplinary collaboration among healthcare providers.

  • Acupuncture: Acupuncture is a traditional Chinese medicine technique that involves the insertion of thin needles into specific points on the body to alleviate pain and promote healing. Recent research has demonstrated the effectiveness of acupuncture in managing various pain conditions, including chronic low back pain, osteoarthritis, and migraine headaches.[23]
  • Mind-body medicine: Mind-body medicine encompasses a variety of techniques, such as biofeedback, hypnosis, and relaxation therapy, that harness the mind’s innate healing abilities to reduce pain and promote well-being. Recent advancements in mind-body medicine have included the development of virtual reality (VR) and augmented reality (AR) interventions for pain management, as well as the integration of biofeedback and neurofeedback techniques to enhance treatment outcomes.[24]

Other non-pharmacological approaches: In addition to physical therapy, mind-body interventions, and complementary therapies, several other non-pharmacological approaches have shown promise in pain management:

  • Nutritional interventions: Emerging research suggests that dietary factors may influence pain perception and inflammation. Nutritional interventions such as anti-inflammatory diets, omega-3 fatty acid supplementation, and gut microbiome modulation have been investigated for their potential role in managing chronic pain conditions.[25]
  • Sleep hygiene: Sleep disturbances are common in patients with chronic pain and can exacerbate pain severity and functional impairment. Recent advancements in sleep medicine have focused on promoting sleep hygiene practices, cognitive-behavioral therapy for insomnia (CBT-I), and pharmacological interventions to improve sleep quality and pain outcomes.[26]
  • Pain neuroscience education (PNE): PNE is an educational approach that aims to empower patients by providing them with a better understanding of the neurophysiological mechanisms underlying pain. Recent research has shown that PNE can reduce pain catastrophe, fear avoidance behaviors, and healthcare utilization in patients with chronic pain conditions.[27]

These recent non-pharmacological advances offer complementary and integrative approaches to pain management, addressing the multidimensional nature of pain and promoting overall well-being in patients.

Interventional Approaches
Interventional approaches to pain management involve minimally invasive procedures aimed at diagnosing and treating pain conditions by targeting specific pain generators and pain pathways.[28] These approaches include nerve blocks, epidural injections, radiofrequency ablation, and neuromodulation techniques. This section will explore recent advances in interventional pain management and their applications in clinical practice.

Nerve blocks: Nerve blocks are procedures that involve the injection of local anesthetics or neurolytic agents into nerves or nerve plexuses to block pain signals from reaching the brain.[29] Recent advancements in nerve block techniques have focused on improving precision, safety, and efficacy while minimizing procedural risks and patient discomfort.

Peripheral nerve blocks: Peripheral nerve blocks involve the injection of local anesthetics or corticosteroids around peripheral nerves to provide targeted pain relief for various acute and chronic pain conditions. Recent advancements in ultrasound-guided nerve block techniques have improved accuracy and efficacy, allowing for real-time visualization of nerve structures and needle placement.[30]

Sympathetic nerve blocks: Sympathetic nerve blocks target the sympathetic nervous system to relieve pain associated with complex regional pain syndrome (CRPS), sympathetically mediated pain, and vascular disorders. Recent research has explored novel approaches to sympathetic nerve blockades, such as chemical neurolysis using alcohol or phenol and radiofrequency ablation of sympathetic ganglia, to achieve long-lasting pain relief.[31]

Epidural Injections: Epidural injections involve the administration of corticosteroids or local anesthetics into the epidural space to reduce inflammation and alleviate pain associated with spinal nerve compression and radiculopathy.[32] Recent advancements in epidural injection techniques have focused on optimizing medication delivery, patient selection, and procedural outcomes.

Transforaminal epidural injections: Transforaminal epidural injections target the spinal nerve roots as they exit the intervertebral foramina, providing targeted pain relief for radicular pain conditions such as sciatica and spinal stenosis. Recent studies have investigated the efficacy of transforminal epidural injections compared to other injection techniques, as well as the use of adjunctive therapies such as platelet-rich plasma (PRP) and stem cell therapy.[33]

Interlaminar epidural injections: Interlaminar epidural injections involve the administration of medication into the epidural space via a midline approach, targeting the affected spinal segments. Recent advancements in interlaminar epidural injection techniques have included the use of fluoroscopy or ultrasound guidance to improve accuracy and reduce procedural complications.[34]

Radiofrequency ablation (RFA): RFA is a minimally invasive procedure that uses heat generated by radiofrequency energy to disrupt pain signals transmitted by sensory nerves.[35] Recent advancements in RFA techniques have focused on refining electrode design, optimizing energy delivery parameters, and expanding indications for various pain conditions.

Conventional RFA: Conventional RFA involves the placement of a radiofrequency electrode near the target nerve under fluoroscopic guidance, followed by the application of thermal energy to create a lesion and disrupt pain transmission. Recent studies have investigated the use of cooled radiofrequency (CRF) techniques to minimize tissue damage and improve the safety profile of RFA procedures.[36]

Pulsed radiofrequency (PRF): PRF delivers short bursts of radiofrequency energy to the target nerve, creating a neuromodulator effect without causing tissue destruction. Recent research has explored the use of PRF for various pain conditions, including neuropathic pain, osteoarthritis, and cancer pain, with promising results in terms of pain relief and functional improvement.[37]

Neuromodulation techniques: Neuromodulation techniques, such as spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS), involve the delivery of electrical impulses to modulate pain signals within the nervous system.[38] Recent advancements in neuromodulation technology have focused on improving device design, programming algorithms, and patient selection criteria to optimize therapeutic outcomes.

SCS: SCS delivers electrical impulses to the spinal cord via implanted electrodes, disrupting pain signals and producing paresthesia or tingling sensations that mask pain perception. Recent advancements in SCS technology have included the development of high-frequency (HF-SCS) and burst stimulation paradigms, as well as the integration of closed-loop feedback systems to enhance pain relief and minimize paresthesia.[39]

PNS: PNS involves the implantation of electrodes near peripheral nerves to deliver electrical impulses and modulate pain signals. Recent research has focused on identifying optimal target nerves and stimulation parameters for specific pain conditions, as well as exploring novel approaches such as ultrasound-guided PNS and minimally invasive surgical techniques.[40]

These recent interventional advances offer minimally invasive and targeted approaches to pain management, providing patients with alternative treatment options when conservative therapies fail to provide adequate relief.

Multidisciplinary Approaches
Multidisciplinary pain management programs integrate various healthcare disciplines and therapeutic modalities to address the complex biopsychosocial aspects of pain.[41] These programs aim to provide comprehensive care that addresses not only the physical aspects of pain but also the psychological, social, and functional dimensions. This section will explore recent advances in multidisciplinary pain management and their applications in clinical practice.

Comprehensive assessment and treatment planning: Multidisciplinary pain management begins with a comprehensive assessment of the patient’s pain experience, functional limitations, psychosocial factors, and treatment goals.[42] Recent advancements in assessment tools and treatment planning strategies have focused on improving patient outcomes and optimizing resource utilization.

Biopsychosocial assessment: Biopsychosocial assessment tools, such as the McGill Pain Questionnaire and the Pain Catastrophizing Scale, are used to evaluate pain intensity, pain-related disability, psychological distress, and coping mechanisms. Recent research has highlighted the importance of integrating patient-reported outcome measures (PROMs) and electronic health record (EHR) data to facilitate personalized treatment planning and outcome tracking.[43]

Individualized treatment plans: Individualized treatment plans are developed based on the multidisciplinary assessment findings and patient preferences. Recent advancements in treatment planning have emphasized the use of evidence-based interventions, shared decision-making principles, and collaborative care models involving patients, caregivers, and healthcare providers.[44]

Collaborative care delivery models: Collaborative care delivery models involve interdisciplinary teamwork and communication to coordinate care across different healthcare settings and specialties.[45] Recent advancements in collaborative care models have focused on enhancing care coordination, continuity, and integration to improve patient outcomes and reduce healthcare costs.

Interprofessional collaboration: Interprofessional collaboration involves healthcare providers from different disciplines working together to address the complex needs of patients with chronic pain. Recent research has emphasized the role of team-based care models, case conferences, and care coordination protocols in optimizing pain management outcomes.[46]

Integrated care pathways: Integrated care pathways provide standardized protocols and algorithms for the assessment, treatment, and follow-up of patients with chronic pain. Recent advancements in integrated care pathways have included the incorporation of telehealth services, remote monitoring technologies, and virtual care platforms to enhance accessibility and continuity of care.[47]

Patient-centered care and shared decision making: Patient-centered care emphasizes active patient involvement in treatment decisions, goal setting, and self-management strategies.[48] Recent advancements in patient-centered care models have focused on promoting autonomy, empowerment, and engagement to improve treatment adherence and satisfaction.

Shared decision making: Shared decision making involves collaborative discussions between patients and healthcare providers to explore treatment options, weigh risks and benefits, and make informed decisions based on individual preferences and values. Recent research has highlighted the importance of decision support tools, decision aids, and patient education materials in facilitating shared decision making and enhancing patient-provider communication.[49]

Self-management strategies: Self-management strategies empower patients to take an active role in managing their pain and improving their quality of life. Recent advancements in self-management interventions have included the integration of behavioral therapies, mindfulness-based interventions, and digital health technologies to support self-monitoring, self-care activities, and symptom management.[50]

Conclusion

In conclusion, recent advancements in pain management have significantly expanded the range of treatment options available to patients and healthcare providers. From pharmacological interventions and interventional procedures to non-pharmacological approaches and multidisciplinary care models, these advances offer tailored and holistic approaches to pain management that address the diverse needs of patients. By leveraging the latest evidence-based practices and innovative technologies, healthcare providers can optimize pain management outcomes and improve the overall quality of life for individuals living with pain.

Looking ahead, continued research and innovation are needed to further refine existing treatments and develop novel approaches to pain management. By prioritizing patient-centered care, interdisciplinary collaboration, and evidence-based practice, healthcare providers can continue to advance the field of pain management and improve the lives of patients worldwide.

References

  1. Raja SN, Carr DB, Cohen M, et al. The revised International Association for the Study of Pain definition of pain: Concepts, challenges, and compromises. Pain. 2020;161(9):1976-1982. doi:10.1097/j.pain.0000000000001939 PubMed | Crossref | Google Scholar
  2. Benyamin R, Trescot AM, Datta S, Buenaventura R, Adlaka R, Sehgal N, Glaser SE, Vallejo R. Opioid complications and side effects. Pain Physician. 2008 Mar;11(2 Suppl):S105-20. PubMed | Crossref | Google Scholar
  3. Kaye AD, Jones MR, Kaye AM, et al. Prescription opioid abuse in chronic pain: An updated review of opioid abuse predictors and strategies to curb opioid abuse. Pain Physician. 2017;20(2S). PubMed | Crossref | Google Scholar
  4. Lee CR, McTavish D, Sorkin EM. Tramadol: A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states. Drugs. 1993;46(2):313-340. doi:10.2165/00003495-199346020-00008 PubMed | Crossref | Google Scholar
  5. Tzschentke TM, Christoph T, Kögel B, et al. Tapentadol hydrochloride: A next-generation, centrally acting analgesic with two mechanisms of action in a single molecule. Drugs Today (Barc). 2009;45(7):483-496. doi:10.1358/dot.2009.45.7.1395291 PubMed | Crossref | Google Scholar
  6. Khanna IK, Pillarisetti S. Buprenorphine: An attractive opioid with underutilized potential in treatment of chronic pain. J Pain Res. 2015;8:859-870. doi:10.2147/JPR.S85951 PubMed | Crossref | Google Scholar
  7. Woolf CJ, Mannion RJ. Neuropathic pain: Aetiology, symptoms, mechanisms, and management. Lancet. 1999;353(9168):1959-1964. doi:10.1016/s0140-6736(99)01307-0 PubMed | Crossref | Google Scholar
  8. Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action. Pain. 1999;83(3):389-400. doi:10.1016/s0304-3959(99)00154-2 PubMed | Crossref | Google Scholar
  9. Moore RA, Wiffen PJ, Derry S, Toelle T, Rice AS. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2014;(4). doi:10.1002/14651858.CD007938.pub3 PubMed | Crossref | Google Scholar
  10. Petrenko AB, Yamakura T, Baba H, Shimoji K. The role of N-methyl-D-aspartate (NMDA) receptors in pain: A review. Anesth Analg. 2003;97(4):1108-1116. doi:10.1213/01.ane.0000081061.12235.55 PubMed | Crossref | Google Scholar
  11. Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26(11):1261-1268. PubMed | Crossref | Google Scholar
  12. Berner B, John VA. Pharmacokinetic characterization of transdermal delivery systems. Clin Pharmacokinet. 1994;26(2):121-134. doi:10.2165/00003088-199426020-00005 PubMed | Crossref | Google Scholar
  13. Hayek SM, Deer TR, Pope JE, Panchal SJ, Patel VB. Intrathecal therapy for cancer and non-cancer pain. Pain Physician. 2011;14(3):219-248. PubMed | Crossref | Google Scholar
  14. Allen TM, Cullis PR. Liposomal drug delivery systems: From concept to clinical applications. Adv Drug Deliv Rev. 2013;65(1):36-48. doi:10.1016/j.addr.2012.09.037 PubMed | Crossref | Google Scholar
  15. Gatchel RJ, Peng YB, Peters ML, Fuchs PN, Turk DC. The biopsychosocial approach to chronic pain: Scientific advances and future directions. Psychol Bull. 2007;133(4):581-624. doi:10.1037/0033-2909.133.4.581 PubMed | Crossref | Google Scholar
  16. Fritz JM, Cleland JA, Brennan GP. Does adherence to the guideline recommendation for active treatments improve the quality of care for patients with acute low back pain delivered by physical therapists? Med Care. 2007;45(10):973-980. doi:10.1097/mlr.0b013e318070c6cd PubMed | Crossref | Google Scholar
  17. Bialosky JE, Bishop MD, George SZ. The mechanisms of manual therapy in the treatment of musculoskeletal pain: A comprehensive model. Man Ther. 2009;14(5):531-538. doi:10.1016/j.math.2008.09.001 PubMed | Crossref | Google Scholar
  18. Hayden JA, van Tulder MW, Malmivaara A, Koes BW. Exercise therapy for treatment of non-specific low back pain. Cochrane Database Syst Rev. 2005;(3). doi:10.1002/14651858.CD000335.pub2 PubMed | Crossref | Google Scholar
  19. Kabat-Zinn J, Lipworth L, Burney R. The clinical use of mindfulness meditation for the self-regulation of chronic pain. J Behav Med. 1985;8(2):163-190. doi:10.1007/bf00845519 PubMed | Crossref | Google Scholar
  20. Cherkin DC, Sherman KJ, Balderson BH, et al. Effectiveness of mindfulness-based stress reduction vs cognitive behavioral therapy or usual care for chronic low back pain: A randomized clinical trial. JAMA. 2016;315(12):1240-1249. doi:10.1001/jama.2016.2323 PubMed | Crossref | Google Scholar
  21. Ehde DM, Dillworth TM, Turner JA. Cognitive-behavioral therapy for individuals with chronic pain: Efficacy, innovations, and directions for research. Am Psychol. 2014;69(2):153-166. doi:10.1037/a0035747 PubMed | Crossref | Google Scholar
  22. Kligler B, Teets R, Quick M. Complementary/integrative therapies that work: A review of the evidence. Am Fam Physician. 2016;94(5):369-374. PubMed Google Scholar
  23. Vickers AJ, Linde K. Acupuncture for chronic pain. JAMA. 2014;311(9):955-956. doi:10.1001/jama.2013.285478 PubMed | Crossref | Google Scholar
  24. Jensen MP, Day MA, Miró J. Neuromodulatory treatments for chronic pain: Efficacy and mechanisms. Nat Rev Neurol. 2014;10:167-178. doi:10.1038/nrneurol.2014.12 PubMed | Crossref | Google Scholar
  25. Elma Ö, Brain K, Dong HJ. The importance of nutrition as a lifestyle factor in chronic pain management: A narrative review. J Clin Med. 2022;11(19):5950. doi:10.3390/jcm11195950 PubMed | Crossref | Google Scholar
  26. Finan PH, Goodin BR, Smith MT. The association of sleep and pain: An update and a path forward. J Pain. 2013;14(12):1539-1552. doi:10.1016/j.jpain.2013.08.007 PubMed | Crossref | Google Scholar
  27. Melzack R, Wall PD. Pain mechanisms: A new theory. Science. 1965;150(3699):971-979. doi:10.1126/science.150.3699.971 PubMed | Crossref | Google Scholar
  28. Woolf CJ. What is this thing called pain? J Clin Invest. 2010;120(11):3742-3744. doi:10.1172/jci45178 PubMed | Crossref | Google Scholar
  29. Katz J, Seltzer Z. Transition from acute to chronic postsurgical pain: Risk factors and protective factors. Expert Rev Neurother. 2009;9(5):723-744. doi:10.1586/ern.09.20 PubMed | Crossref | Google Scholar
  30. Jensen MP, Turk DC. Contributions of psychology to the understanding and treatment of people with chronic pain: Why it matters to ALL psychologists. Am Psychol. 2014;69(2):105-118. doi:10.1037/a0035641 PubMed | Crossref | Google Scholar
  31. Gatchel RJ, Okifuji A. Evidence-based scientific data documenting the treatment and cost-effectiveness of comprehensive pain programs for chronic non-malignant pain. J Pain. 2006;7(11):779-793. doi:10.1016/j.jpain.2006.08.005 PubMed | Crossref | Google Scholar
  32. Breivik H, Collett B. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. Eur J Pain. 2006;10(4):287-333. doi:10.1016/j.ejpain.2005.06.009 PubMed | Crossref | Google Scholar
  33. Turk DC, Okifuji A. Assessment of patients’ reporting of pain: An integrated perspective. Lancet. 2001;357(9263):210-216. doi:10.1016/s0140-6736(99)01309-4 PubMed | Crossref | Google Scholar
  34. Manchikanti L, Singh V, Falco FJ, Benyamin RM, Hirsch JA. Utilization patterns of facet joint interventions in managing spinal pain: A retrospective evaluation of Medicare data. Pain Physician. 2013;16(4). doi:10.1007/s11916-019-0816-7 PubMed | Crossref | Google Scholar
  35. Turk DC, Monarch ES. Biopsychosocial perspective on chronic pain. In: Gatchel RJ, Turk DC, eds. Psychological Approaches to Pain Management: A Practitioner’s Handbook. 2nd ed. New York, NY: Guilford Press; 2002:3-29. Google Scholar
  36. Melzack R. Pain and the neuromatrix in the brain. J Dent Educ. 2001;65(12):1378-1382. PubMed | Crossref | Google Scholar
  37. Turk DC, Gatchel RJ, eds. Psychological Approaches to Pain Management: A Practitioner’s Handbook. 3rd ed. New York, NY: Guilford Press; 2018. Google Scholar
  38. Gatchel RJ, Turk DC, eds. Psychological Approaches to Pain Management: A Practitioner’s Handbook. 2nd ed. New York, NY: Guilford Press; 2008. doi:10.1016/S0022-3999(96)00324-8 Crossref
  39. Breivik H, Collett B. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. Eur J Pain. 2006;10(4):287-333. doi:10.1016/j.ejpain.2005.06.009 PubMed | Crossref | Google Scholar
  40. Turk DC, Okifuji A. Assessment of patients’ reporting of pain: An integrated perspective. Lancet. 2001;357(9263):210-216. doi:10.1016/s0140-6736(99)01309-4 PubMed | Crossref | Google Scholar
  41. Kaiser U, Arnold B, Pfingsten M, Nagel B, Lutz J, Sabatowski R. Multidisciplinary pain management programs. J Pain Res. 2013;6:355-358. doi:10.2147/JPR.S40512 PubMed | Crossref | Google Scholar
  42. Turk DC, Monarch ES. Biopsychosocial perspective on chronic pain. In: Gatchel RJ, Turk DC, eds. Psychological Approaches to Pain Management: A Practitioner’s Handbook. 2nd ed. New York, NY: Guilford Press; 2002:3-29. Google Scholar
  43. Melzack R. Pain and the neuromatrix in the brain. J Dent Educ. 2001;65(12):1378-1382. PubMed | Crossref | Google Scholar
  44. Turk DC, Gatchel RJ, eds. Psychological Approaches to Pain Management: A Practitioner’s Handbook. 3rd ed. New York, NY: Guilford Press; 2018. Google Scholar
  45. Nielson WR, Weir R. Biopsychosocial approaches to the treatment of chronic pain. Curr Opin Psychiatry. 2001;14(1):91-96. doi:10.1097/00002508-200112001-00020 PubMed | Crossref | Google Scholar
  46. Melzack R. Pain and the neuromatrix in the brain. J Dent Educ. 2001;65(12):1378-1382. PubMed | Crossref | Google Scholar
  47. Turk DC, Gatchel RJ, eds. Psychological Approaches to Pain Management: A Practitioner’s Handbook. 3rd ed. New York, NY: Guilford Press; 2018. Google Scholar
  48. Turk DC, Okifuji A. Assessment of patients’ reporting of pain: An integrated perspective. Lancet. 2001;357(9263):210-216. doi:10.1016/s0140-6736(99)01309-4 PubMed | Crossref | Google Scholar
  49. Stacey D, Légaré F, Lewis K, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2017;4(4). doi:10.1016/s0140-6736(99)01309-4 PubMed
  50. Turk DC, Monarch ES. Biopsychosocial perspective on chronic pain. In: Gatchel RJ, Turk DC, eds. Psychological Approaches to Pain Management: A Practitioner’s Handbook. 2nd ed. New York, NY: Guilford Press; 2002:3-29. Google Scholar

Acknowledgments

Not reported

Funding

Not reported

Author Information

Muhammad Kazim Bashir
Department of General Medicine
Letterkenny University Hospital, Ireland
Email: kazimsahab97@gmail.com

Author Contribution

The author contributed to the conceptualization, investigation, and data curation by acquiring and critically reviewing the selected articles and was involved in the writing – original draft preparation and writing – review & editing to refine the manuscript.

Ethical Approval

Not applicable

Conflict of Interest Statement

Not reported

Guarantor

None

DOI

https://doi.org/10.63096/medtigo30622432

Cite this Article

Muhammad KB. Recent advances in pain management. medtigo J Med. 2024;2(4):e30622432. doi:10.63096/medtigo30622432 Crossref

ALTMETRICS

Citations 3

Cite This